Spineart specializes in creating innovative spinal implants to streamline complex surgeries, providing cutting-edge solutions for healthcare professionals.

ObsEva SA is a Swiss-based, speciality biopharmaceutical company dedicated to the development of innovative drugs for women's reproductive medicine. ObsEva's main focus is on therapies for preterm labor. ObsEva was founded in November 2012, by Ernest Loumaye MD, PhD and André Chollet PhD. Ernest Loumaye is a specialist in female reproductive medicine with 20 years of experience in the biopharmaceutical industry. Ernest Loumaye was previously Co-Founder and CEO of PregLem SA, a successful biopharmaceutical company which was acquired by Gedeon Richter in 2010. André Chollet is specialist in medicinal and pharmaceutical chemistry with more than 30 years of experience in diverse positions in the biopharmaceutical industry, including in Biogen, GSK and Merck Serono. André Chollet was responsible for the preterm labor program at Serono before the acquisition of the company by Merck KGaA.

Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators for neurological disorders. Its modulators offer several potential advantages over conventional non-allosteric molecules and may offer an improved therapeutic approach to conventional ""orthosteric"" small molecules or biological drugs. Its allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention.

Calypso Biotech aims to bring hope to patients with severe gastro-intestinal diseases. Their mission is to provide innovative treatments for those in need, offering new possibilities for improved health and well-being.

Medimaps Group is a Swiss company creating user-friendly solutions for clinical use. Their innovative approach streamlines processes for healthcare professionals, improving efficiency and patient care.

A cutting-edge 3D graphics company offering live hologram video technology for telepresence, broadcasting, and installations. Experience immersive 3D visuals with our innovative solutions.

Adiposs, a biotech start-up, develops innovative solutions for obesity treatment. Their cutting-edge products aim to provide effective and sustainable weight management options.

Hardware & IoT

Silver Wave Medical specializes in anti-aging services and personalized patient-physician matching. Discover a new way to enhance your well-being and connect with trusted healthcare professionals.

MPC Therapeutics is a biotechnology company. For patients with cancer and degenerative disorders, the company is presently concentrating on creating life-altering medications. They develop a class of compounds with the ability to modify mitochondrial processes in order to alter the conductivity of the cell and prevent the growth of diseases by using their medicinal chemistry and mitochondrial biology.

Mikajaki is an advanced automated ocular diagnostics platform that leverages digital technology, robotics, and AI. It empowers patients and eye specialists with tailored treatments, streamlining the diagnostic process and enhancing access to essential eye care solutions.

Prodibi is a platform that lets users showcase high resolution images without any size restrictions. Show off your photos in stunning detail with this online tool.

Alohi offers two innovative platforms: SIGN.PLUS for legally binding electronic signatures and FAX.PLUS for self-service communications. Designed for enterprises, businesses, and individual consumers, these solutions streamline processes and boost efficiency, making them essential tools for a diverse range of users.

Spineart specializes in creating innovative spinal implants to streamline complex surgeries, providing cutting-edge solutions for healthcare professionals.

ObsEva SA is a Swiss-based, speciality biopharmaceutical company dedicated to the development of innovative drugs for women's reproductive medicine. ObsEva's main focus is on therapies for preterm labor. ObsEva was founded in November 2012, by Ernest Loumaye MD, PhD and André Chollet PhD. Ernest Loumaye is a specialist in female reproductive medicine with 20 years of experience in the biopharmaceutical industry. Ernest Loumaye was previously Co-Founder and CEO of PregLem SA, a successful biopharmaceutical company which was acquired by Gedeon Richter in 2010. André Chollet is specialist in medicinal and pharmaceutical chemistry with more than 30 years of experience in diverse positions in the biopharmaceutical industry, including in Biogen, GSK and Merck Serono. André Chollet was responsible for the preterm labor program at Serono before the acquisition of the company by Merck KGaA.

Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators for neurological disorders. Its modulators offer several potential advantages over conventional non-allosteric molecules and may offer an improved therapeutic approach to conventional ""orthosteric"" small molecules or biological drugs. Its allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention.

CommoChain streamlines the trading of commodities and raw materials for exporters and importers by simplifying their back-office operations. This innovative platform enhances efficiency and reduces complexities, allowing businesses to focus on growth and success in the global marketplace.

Spineart specializes in creating innovative spinal implants to streamline complex surgeries, providing cutting-edge solutions for healthcare professionals.

Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators for neurological disorders. Its modulators offer several potential advantages over conventional non-allosteric molecules and may offer an improved therapeutic approach to conventional ""orthosteric"" small molecules or biological drugs. Its allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention.

ObsEva SA is a Swiss-based, speciality biopharmaceutical company dedicated to the development of innovative drugs for women's reproductive medicine. ObsEva's main focus is on therapies for preterm labor. ObsEva was founded in November 2012, by Ernest Loumaye MD, PhD and André Chollet PhD. Ernest Loumaye is a specialist in female reproductive medicine with 20 years of experience in the biopharmaceutical industry. Ernest Loumaye was previously Co-Founder and CEO of PregLem SA, a successful biopharmaceutical company which was acquired by Gedeon Richter in 2010. André Chollet is specialist in medicinal and pharmaceutical chemistry with more than 30 years of experience in diverse positions in the biopharmaceutical industry, including in Biogen, GSK and Merck Serono. André Chollet was responsible for the preterm labor program at Serono before the acquisition of the company by Merck KGaA.

Spineart specializes in creating innovative spinal implants to streamline complex surgeries, providing cutting-edge solutions for healthcare professionals.

ObsEva SA is a Swiss-based, speciality biopharmaceutical company dedicated to the development of innovative drugs for women's reproductive medicine. ObsEva's main focus is on therapies for preterm labor. ObsEva was founded in November 2012, by Ernest Loumaye MD, PhD and André Chollet PhD. Ernest Loumaye is a specialist in female reproductive medicine with 20 years of experience in the biopharmaceutical industry. Ernest Loumaye was previously Co-Founder and CEO of PregLem SA, a successful biopharmaceutical company which was acquired by Gedeon Richter in 2010. André Chollet is specialist in medicinal and pharmaceutical chemistry with more than 30 years of experience in diverse positions in the biopharmaceutical industry, including in Biogen, GSK and Merck Serono. André Chollet was responsible for the preterm labor program at Serono before the acquisition of the company by Merck KGaA.

Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators for neurological disorders. Its modulators offer several potential advantages over conventional non-allosteric molecules and may offer an improved therapeutic approach to conventional ""orthosteric"" small molecules or biological drugs. Its allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention.

Calypso Biotech aims to bring hope to patients with severe gastro-intestinal diseases. Their mission is to provide innovative treatments for those in need, offering new possibilities for improved health and well-being.

Alohi offers two innovative platforms: SIGN.PLUS for legally binding electronic signatures and FAX.PLUS for self-service communications. Designed for enterprises, businesses, and individual consumers, these solutions streamline processes and boost efficiency, making them essential tools for a diverse range of users.

Spineart specializes in creating innovative spinal implants to streamline complex surgeries, providing cutting-edge solutions for healthcare professionals.

Popety.io empowers real estate agents to streamline their prospecting and analysis efforts with user-friendly digital solutions. By simplifying data collection, analysis, and formatting, it significantly reduces the time agents spend on these tasks, enabling them to focus more on building client relationships and closing deals.